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BACKGROUND: Closed-loop control of the hypnotic component of anesthesia has been
proposed in an attempt to optimize drug delivery. Here, we introduce a newly
developed Bayesian-based, patient-individualized, model-based, adaptive control
method for bispectral index (BIS) guided propofol infusion into clinical practice
and compare its accuracy and clinical feasibility under direct observation of an
anesthesiologist versus BIS guided, effect compartment controlled propofol adminis-
tration titrated by the anesthesiologist during ambulatory gynecological procedures.
METHODS: Forty ASA patients were randomly allocated to the closed-loop or manual
control group. All patients received midazolam 1 mg IV and alfentanil 0.5 mg IV
before induction. In the closed-loop control group, propofol was administered
using the previously described closed-loop control system to reach and maintain a
target BIS of 50. In the manual control group, the propofol effect-site concentration
was adapted at the discretion of the anesthesiologist to reach and maintain a BIS as
close as possible to 50. Induction characteristics, performance, and robustness
during maintenance and recovery times were compared. Hemodynamic and
respiratory stability were calculated as clinical feasibility parameters.
RESULTS: The closed-loop control system titrated propofol administration accurately
resulting in BIS values close to the set point. The closed-loop control system was
able to induce the patients within clinically accepted time limits and with less
overshoot than the manual control group. Automated control resulted in beneficial
recovery times. Our closed-loop control group showed similar acceptable clinical
performance specified by similar hemodynamic, respiratory stability, comparable
movement rates, and quality scores than the manual control group.
CONCLUSIONS: The Bayesian-based closed-loop control system for propofol admin-
istration using the BIS as a controlled variable performed accurate during anesthe-
sia for ambulatory gynecological procedures. This control system is clinical
feasibility and can be further validated in clinical practice.
(Anesth Analg 2008;107:1200–10)
Closed-loop control of the hypnotic component of
anesthesia has been proposed in an attempt to optimize
drug delivery.1 Various automated drug delivery systems
have been described in the literature using spontane-
ous electroencephalogram2–10 or auditory evoked po-
tential indices11 as controlled variables. However,
several limitations such as lack of control during
induction, exclusion of already anesthetized patients
when applying model-based controllers, and prob-
lems dealing with patient variability during control
have been encountered in previous work. Outside
anesthesia, adaptive control has been well used in
medicine for decades, for example, to control nitro-
prusside infusions.12
Our group has developed a new model-based
patient-individualized closed loop control system
for propofol administration using the bispectral
index (BIS) as a controlled variable taking care of
these limitations by implementing Bayesian meth-
odology. Recently, we have applied simulations to
select these Bayesian variances yielding the optimal
controller for this Bayesian-based control system.13
Bayesian optimization, as proposed by Sheiner and
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coworkers,14 individualize the pharmacodynamic
relationship by combining individual information
with the knowledge of an a priori probability density
function containing the statistical properties of the
parameter to be estimated.15 The Bayesian method
starts from a standard, population-based response
model providing the prior distribution of parameter
values. These values are adjusted to reflect the
patient’s own parameters over time, based on the
observed response of the individual patient under
varying circumstances. This process makes use of
specific modeling weights, called Bayesian vari-
ances, which determine how the patient-specific
model can deviate from the population model.
These Bayesian variances need to be optimized for
control performance in a target population, which
was done for this controller and described in previ-
ous work.13
The aim of this study was to introduce this newly
developed system into clinical practice and compare
its accuracy and clinical feasibility under direct
observation of an anesthesiologist versus BIS
guided, effect compartment controlled propofol ad-
ministration titrated by the anesthesiologist during
ambulatory gynecological procedures. The main
novelty in this investigation compared with the
referenced studies is that the new control system
enables us to include the induction phase in the
closed-loop control mode of the controller rather
than only the maintenance phase.
METHODS
System Specifications
Controlled Variable, Data Management, and
Actuator Control
The BIS was applied as controlled variable to titrate
propofol administration. BIS (BIS-XP®, version 4) is
derived from the frontal electroencephalogram as cal-
culated by the A-2000 BIS® Monitor (Aspect Medical
Systems, Inc., Norwood, MA) using four BIS-Sensor
electrodes (Aspect Medical Systems).
In all patients, our setup used a laptop running
RUGLOOPII1* to calculate the target controlled infu-
sion (TCI) algorithms to steer the infusion pump, and
to record all relevant physiologic data including the
BIS signal. The target controlled infusion system used
a three compartment model with an effect compart-
ment, previously published by Schnider et al.16,17 As
in a previous study of Struys et al.,18 for the calcula-
tion of the propofol effect-site concentration
(CePROP) a fixed time-to-peak effect site concentra-
tion19 of 1.6 min was used, as also published by
Schnider et al.17
In the closed-loop control group, the RUGLOOPII
platform also executed the closed-loop control, calcu-
lating an adequate propofol effect-site concentration
from the measured BIS, to serve as the input to the
effect compartment controlled TCI system. In the
control group, the anesthetist applied the TCI system
directly to titrate the propofol administration.
Blood pressure, heart rate, end-tidal CO2, and Spo2
were acquired using the S5-monitor. (GE Healthcare,
Helsinki, Finland.). All data were stored on hard disk
at a 5-s interval.
Closed-Loop Controller
The closed-loop control algorithm attempts to mini-
mize the error between the measured BIS value and
the target BIS value selected by the anesthesiologist by
calculating an adequate propofol effect-site concen-
tration using a patient-individualized, model-based,
adaptive control method. The applied model-based
adaptive control system with Bayesian model opti-
mization is described extensively in our previous
work.13
The controller is based on a pharmacodynamic
model represented by a patient-individualized sig-
moid Emax model, describing the relation between
BIS and CePROP, and characterized by four param-
eters: E0 equals the BIS value at no drug effect; Emax
equals the change in BIS between no drug effect and
maximum drug effect; EC50 represents the CePROP
at 50% of effect; and  represents the steepness of
drug effect around 50%. The model can be
presented as:
BIS  E0  (E0  Emax)   CePROP
CePROP  EC50
 (1)
The controller estimates the target propofol effect-site
concentration that will minimize the difference be-
tween measured and target value for the controlled
variable (BIS) by shifting the sigmoid Emax model
along the propofol effect-site concentration axis. A
detailed explanation of this “moving curve controller”
can be found in our previous work.10
Originally, the patient-specific sigmoid Emax curve
was estimated during induction and used unchanged
throughout the case. Recently, the model estimator
was improved by implementing a Bayesian technique
to continuously calculate a patient-individualized sig-
moid Emax combining an initial population mean
model with the observed responses over the entire
course of the anesthetic. The development of and the
estimation of the optimal modeling weights for this
Bayesian-based closed loop control system were
*RUGLOOP II, written by Tom De Smet, MSc (medical engineer,
DEMED Engineering, Temse, Belgium) and Michel MRF Struys,
MD, PhD(Professor of Anesthesia, Ghent University, Gent, Bel-
gium) More information available at http://www.anesthesia-
uzgent.be, latest accessed on August 23, 2007.
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reported previously.13 Generally, the Bayesian objec-
tive function looks like:


















whereby BISsample is the observed value and BISestimated is
the estimated value based on the model to be fitted.
EC50 and  are the nonfixed terms of the sigmoid Emax
model, “Population” is the original population refer-
ence model parameter (a priori information), and
“Estimated” is the estimated value of parameter for
the individual. SampleTO is a forgetting factor repre-
senting the samples taken into account for the model-
ing on a time-limited base, and D is the systems delay
to be estimated.
Clinical Study
After Institutional Ethics Committee (Ethics Com-
mittee of the Ghent University Hospital, Gent, Bel-
gium) approval, informed consent was obtained from
40 ASA I and II female patients, aged 18–45 yr,
scheduled for ovum retrieval, whereby ovocytes are
collected from the follicles in the ovaries by aspiration
using ultrasonic-guided needle puncture through the
vaginal wall. They were randomly (permuted block
randomization, blocks of 4, 20 patients per group)
allocated to the closed-loop or manual control group.
Exclusion criteria included weight 70% or more than
130% of ideal body weight, neurological disorder, and
use of psychoactive medication including alcohol. All
patients received midazolam 1 mg IV 7 min and
alfentanil 0.5 mg IV 2 min before induction with
propofol. All drugs were administered via a large left
forearm vein. Every patient received about 300 mL of
crystalloid fluid during the study period. No fluid
load was given before induction. No other drugs were
given, except paracetamol 1 g IV at the end of the
procedure to provide postoperative pain relief. All
patients maintained spontaneous ventilation via a
facemask delivering oxygen 6 L/min.
In the closed-loop control group, propofol was
administered using the previously described closed-
loop control system. To start and maintain propofol
administration, the requested BIS target was fixed at
50 for the complete duration of the case. In the manual
group, propofol was administered using the effect
compartment controlled TCI system (RUGLOOP). The
initial target propofol effect-site concentration was set
at 5.0 g/mL, which was exactly similar to the initial
EC50 in the initial population model in the closed-loop
controller. The propofol target concentration was
adapted at the discretion of the anesthesiologist (the
same person in all cases) to maintain a BIS as close as
possible to 50.
The time and BIS were recorded at the moment of
LOC. We also calculated the propofol dose used for
the entire procedure. Heart rate, end tidal CO2, Spo2,
and BIS were acquired every 5 s. Artifacts in the BIS
due to poor signal quality were automatically detected
and excluded from further analysis. Blood pressure
was acquired every 1 min. RUGLOOP II digitally
recorded all vital signs and infusion data. During
the case, incidents of spontaneous movement were
documented.
At the end of surgery (i.e., end of surgical stimulus),
propofol administration was stopped and recovery
parameters (time until opening eyes, and time until
saying name and date of birth) were recorded.
Evaluation of the Control Performance
The evaluation methods of the control performance
were described and applied previously.10 BIS was
defined as the controlled variable in both groups and
the BIS target value was set at 50 in both groups.
Controller performance metrics are calculated on the
measured values of the controlled variable versus its
target value. The performance metrics of the closed-loop
and manual control group was evaluated and compared
during induction, maintenance, and recovery.
We recorded time until LOC from the start of
propofol infusion and the amount of propofol used
during induction. The control performance during
induction was studied taking into account the follow-
ing parameters (Fig. 1):
• BISLOC  BIS at the moment of loss of consciousness.
• TBIS TARGET  observed time required for reach-
ing the target BIS value.
Figure 1. Schematic representation of performance during
induction. TLOC  moment of loss of consciousness,
BISLOC  BIS at the moment of loss of consciousness,
TBIS TARGET  observed time required for reaching the target
BIS value, TPEAK, BIS  observed time required for reaching
maximal drug effect (lowest BIS value), BISPEAK  observed
BIS value at TPEAK, BIS, TEQ  observed time required for
reaching the target value after the initial overshoot, also
called time to steady-state.
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• TPEAK, BIS  observed time required for reach-
ing maximal drug effect (lowest BIS value).
• BISPEAK  observed BIS value at TPEAK, BIS.
• TEQ  observed time required for finally reach-
ing the target value with or without overshoot,
also called time to steady-state.
The control performance on the controlled variable
(BIS) was calculated for each patient from the start
until termination of propofol administration using the
following performance metrics.
First, we evaluated the percentage of case time
the BIS remained between 40 – 60 and 45–55. An
important derivative metric is the percentage of
time with too low BIS (lower than 40 or 45, respec-
tively) or too high BIS (higher than 60 or 55,
respectively).
Additionally, the performance-error based method
of Varvel et al.20 was applied. Using all observations
within the period, the performance error (PE) was
calculated according to Equation 2.
PE 
(measured value  target value)
target value
 100 (3)
Subsequently, for each patient bias (median prediction
error [MDPE]), inaccuracy (median absolute perfor-
mance error [MDAPE]), divergence and wobble were
calculated:
• MDPE is a measure of bias and describes whether
the measured values are systematically either
above or below the target value. MDPE was
calculated from
MDPEi  median{PEij, j  1, . . . , Ni} (4)
where Ni is the number of values PE obtained for the
i-th subject.
• MDAPE reflects the inaccuracy of the control
method in the i-th subject:
MDAPEi  medianPEij, j  1, . . . , Ni} (5)
where Ni is the number of values 231 PE obtained for
the i-th subject.
• Divergence describes the possible time-related
trend of the measured effects in relationship to
the targeted values. It is defined as the slope of
the linear regression equation of PE against time
and is expressed in units of percentage diver-
gence per minute. A positive value indicates
progressive widening of the gap between tar-
geted and measured values, whereas a negative
value reveals that the measured values converge
on the predicted values.
• Wobble is another index of the time-related
changes in performance and measures the intra-
subject variability in performance errors. In the
i-th subject, the percentage of wobble is calcu-
lated as follows:
wobblei  median PEij  MDPEi, j  1, . . . , Ni}
(6)
Additionally, we compared hemodynamic (heart
rate and mean arterial blood pressure) and respiratory
(oxygen saturation) stability from start until termina-
tion of the propofol administration between groups.
For heart rate, we evaluated the percentage of case
time heart rate remained between 50 and 90 bpm. As
such, the percentage of time with bradycardia (lower
than 50 bpm) or tachycardia (higher than 90 bpm) was
calculated too. For mean arterial blood pressure, we
evaluated moderate and severe hypotension indicated
by the percentage of case time the blood pressure went
below 60 and 50 mm Hg, respectively, and hyperten-
sion defined by a blood pressure values above 135 mm
Hg.21
During recovery, we compared the time from stop
propofol infusion until opening of the eyes on com-
mand and orientation. Hereby, orientation was de-
fined as saying name and date of birth on request. The
commands for opening of the eyes and orientation
were repeated every 10 s until positive.
In these clinical procedures, patients are allowed to
move smoothly with feet or hands, however, no
movement of the upper legs nor pelvis is allowed as
this might result in dangerous malpositioning of the
needle during the retrieval procedure. Therefore, inci-
dence (number of patients) of allowed and not al-
lowed movements was recorded. Additionally, we
asked the gynecologist at the end of the procedure to
score the overall patients’ anesthetic condition be-
tween 0% and 100%, whereby 0 means very unsafe to
work and 100 means perfect.
Statistical Analysis Used
Power calculations were based on previous stud-
ies.10 For control, overshoot at induction and MDAPE
are important endpoints. For overshoot at induction,
Struys et al.10 found a difference in BISPEAK of 6 BIS
units with a standard deviation of 4. On the basis of
this, 12 patients would be required to show a differ-
ence between groups with a type I and II error of 5%.
For MDAPE, a 30% better result for closed-loop con-
trol versus manual control with a standard deviation
of 25% in both groups would be revealed with a type
I and II error of 5% when studied 18 patients per
group. As such, we included 20 patients per group to
reveal accurate power.
Statistical analysis was performed using SPSS ver-
sion 12.0 (SPSS Inc., Chicago, IL). Data are presented
as mean  sd or as median (range). All data were
checked for Gaussian distribution by the method
of Kolmogorov and Smirnov. Differences between
groups were analyzed by a Student’s t-test or Mann–
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Whitney test, depending on their distribution. Cat-
egorical data (movement) were analyzed by a 2 test.
Evaluation of Bayesian Functionality
The addition of the Bayesian optimization adds
complexity to the control system. This added com-
plexity can only be justified if, at least, the parameters
calculated by the Bayesian optimization for the indi-
vidual patient deviate from the typical values. This
comparison was realized by comparing graphically
the difference in model EC50 and delay, target effect
site concentration change calculated by the controller
using the Bayesian-optimized model versus a hypo-
thetical controller using the unchanged typical values,
as well as the time integration of the latter one.
RESULTS
Similar population demographics were found be-
tween groups for age, weight, and height (Table 1). No
patients were excluded and all data captured by the
recording system were included in the analysis. The
observations made at LOC are listed in Table 2. Some
longer induction times are noticed in the closed-loop
control group. Other clinical parameters during induc-
tion revealed some statistical differences without clini-
cal relevance. Times until first surgical stimulus (not
shown), duration of anesthesia, and total amount of
propofol used were similar in both groups. The per-
formance of the hypnotic control using BIS during the
induction phase is shown in Table 3. Although slower
induction time was observed, similar times to reach
the target BIS were found in the closed-loop control
group than the manual control group. However, the
duration and magnitude of the initial overshoot in BIS
below target was less pronounced in the closed-loop
control group than the manual control group.
The trajectory of BIS between start and termination
of propofol (the real duration of control) for all
individual patients accompanied by the average value
for the group versus time is plotted in Figure 2. As
observed in parts A and B, significant lower BIS values
and more interindividual variability were found in the
manual control group, leading to a significant worse
prediction error over time (parts C and D). Figures 3E
and F shows the individual and averaged CePROP
between start and termination of propofol administra-
tion. It can be noticed that during and shortly after
induction, the CePROP was lower in the closed-loop
control group than manual control group. Addition-
ally, Table 3 proves that the percentages of case time
with accurate BIS control was significantly better in





Age (yr) 31.6  5.3 32.5  5.0
Height (cm) 165.0  5.9 168.8  5.5
Weight (kg) 62.2  9.0 65.4  8.0





Induction time (s) 66  25* 49  9*
Propofol dose until
LOC (mg)
91  22* 106  10*
BISLOC 73  11* 82  7*
Duration of anesthesia
from start until stop
propofol infusion (s)
1013  191 1031  239
Total propofol used
(mg)
261  68 292  67
BIS at stop propofol
administration








215  133* 316  125*
Recovery times until
orientation (s)
259  128* 343  112*
BIS  bispectral index; LOC  loss of consciousness; CePROP  propofol effect-site
concentration.
* P  0.05 between groups.




TBIS TARGET (s) 93  34 89  64
BISpeak 40  7* 33  10*
TPEAK, BIS (s) 125  61 148  112
TEQ (s) 176  101 204  124
a
% of time BIS between
40 and 60
75  13* 43  17*
% of time BIS between
45 and 55
47  13* 20  16*
% of time BIS lower
than 40
15  12* 48  17*
% of time BIS lower
than 45
39  12* 69  17*
% of time BIS higher
than 60
9  3 9  4
% of time BIS higher
than 55
13  3 11  6
% of time HR between
50 and 90 beats/min
100 (6)b 100 (10)b
% of time HR lower
than 50 beats/min
0 (0)b 0 (0)b
% of time HR higher
than 90 beats/min
0 (6)b 0 (10)b
% of time MAP lower
than 60 mm Hg
6 (78)b 6 (87)b
% of time MAP lower
than 50 mm Hg
0 (0)b 0 (3)*
% of time MAP higher
than 135 mm Hg
0 (0)b 0 (0)b
TBIS TARGET  observed time required for reaching the target bispectral index (BIS) value;
BISPEAK  observed BIS value at TPEAK, BIS; TPEAK, BIS  observed time required for reaching
maximal drug effect (lowest BIS value); TEQ  observed time required for reaching the target
value after the initial overshoot; HR  heart rate; MAP  mean arterial blood pressure.
a Only 16 out of the 20 patients returned to BIS target during the entire case.
b These data are presented as median (range).
* P  0.05 between groups.
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the closed-loop control group compared with the
manual group. Significant differences were due to
more too low BIS values in the manual control group.
The overall performance of control for BIS is shown in
Table 4. Performances are calculated from start to stop
of the propofol infusion, except for divergence, which
was analyzed from the moment of TBIS TARGET until
stop of the propofol administration. It was chosen to
use TBIS TARGET rather than TEQ as, in the manual
control group, not all patients reached the target BIS
again. The overall better performance of BIS control in
the closed-loop control group is also proven by ana-
lyzing the PE, MDPE, MDAPE, divergence, and
wobble, which revealed all more advantageous results
for the closed-loop control group compared with the
manual control group.
Hemodynamic stability was similar in both groups
without dangerous alterations due to inaccurate con-
trol. Similar trends in heart rate were found during the
cases in both groups (Figs. 3A and B). No long-lasting
incidences of brady- or tachycardia were noticed
(Table 3). As shown in Figure 3 (C and D), lower blood
pressures were observed in the closed-loop control
group compared with the manual control group be-
tween 300 and 600 s from the start of the propofol
administration. However, this did not result in a
Figure 2. Individual (dotted line) and average (fat line) bispectral index (BIS), performance error (PE), and propofol effect-site
concentration (CePROP) for closed-loop control (parts A, C, and E) and manual control (parts, B, D and F) group. For each
patient, data are represented from start (time  0) until stop of the propofol administration. - and * indicates the time period
during the case that showed significance (P  0.05) between groups.
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higher incidence of moderate nor severe hypotension
(Table 3). No episodes of hypertension were observed
in both groups (Table 3). No patients had respiratory
depression leading to a drop in saturation (data not
shown).
At the end of the procedure, propofol administra-
tion was stopped. BIS and CePROP were similar
between groups at the end of the propofol adminis-
tration. Recovery times were recorded. As shown in
Table 2, times until opening of the eyes and orienta-
tion were significantly shorter in the closed-loop con-
trol group than the manual control group.
Movements were recorded. In the closed-loop
control group, 7 patients showed allowed and 4 not
allowed movements. In the manual control group, 3
patients showed allowed and 5 showed not allowed
movements. None of these events leaded to compli-
cations other than shortlasting interruption of the
retrieval procedure. In the closed-loop control
group, overall quality of anesthesia received a 94%
(11%) score compared with a 89% (17%) score in the
manual control group.
Figure 4 demonstrates the functionality of the
Bayesian modeling. Parts (A) and (B) show a clear
change over time of the calculated EC50 and estimated
delay. As  is not estimated, it has a constant value, as
well as E0 and EMAX (not shown).
More illustrative than the covariate values is the
difference in control behavior, represented in Figures 4C
and D. Part C demonstrates the control action that was
executed by the controller using the Bayesian-optimized
curve, compared with a hypothetical controller that
would use the unchanged typical values (Part D). Unlike
pharmacokinetic datasets, a closed-loop control dataset
cannot be compared against multiple control algorithms
since the post hoc calculated control actions cannot have
a real effect on the patient. Each sample point in Figure
4D therefore should be regarded as an instantaneous
hypothetical control to be applied on the patient’s state
realized by the control history of the original controller.
Consequently, all controllers with identical steady-state
Figure 3. Individual (dotted line) and average (fat line) heart rate from start until stop of the propofol administration for the
closed-loop control (A) and manual control (B) group. Mean arterial blood pressure (MAP) (mean  sd) for closed-loop
control (C) and manual control (D) group. *P  0.05 between groups.
Table 4. Performance of Control for BIS From Start Until
Termination of Propofol Administration
Closed-loop
control Manual-control
Average PE (%) 2.91  24.49* 14.17  28.88*
MDPE (%) 7.78  3.46* 19.96  8.38*
MDAPE (%) 11.51  4.0* 24.06  8.01*
Divergence (% min) 0.009  0.012a 0.004  0.025a
Wobble (%) 8.44  2.84* 11.48  4.19*
PE  prediction error; MDPE  median prediction error; MDAPE  median absolute
performance.
a Divergence was calculated between the moment of TBIS TARGET until termination of the
propofol infusion.
* P  0.05 between groups.
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behavior will show an average control difference
close to zero most of the time. Part E plots the
difference between these control actions to enlarge
the scale. To verify the net effect of the control
difference, the control differences were integrated
over time (Part F) demonstrating the cumulative
control difference.
DISCUSSION
It was hypothesized that the implementation of
Bayesian technology into our previously described and
validated3 patient-individualized, adaptive, model-based
closed-loop control system would allow us to overcome
previous limitations of existing systems hereby guaran-
teeing clinical feasibility and accuracy. We found
Figure 4. Functionality of the Bayesian modeling. Parts (A) and (B) show the change over time of the calculated EC50 and
estimated delay. Part C demonstrates the control action that was executed by the controller using the Bayesian-optimized
curve, compared with a hypothetical controller that would use the unchanged typical values (Part D). Part E plots the
difference between these control actions to enlarge the scale. Part F shows the integration over time (F) to demonstrate the
cumulative difference of the data points shown in part E.
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that our closed-loop control system titrated propofol
administration accurately resulting in BIS values close
to the set point. The closed-loop control system was
able to induce the patients within clinically accepted
time limits and with less overshoot than the manual
control group. Automated control resulted in benefi-
cial recovery times. Our closed-loop control group
showed acceptable performance compared to the
manual control group specified by similar hemody-
namic, respiratory stability, comparable movement, and
quality scores.
The design of this investigation was carefully con-
sidered. In previous work from our group,10 some of
our methodology was criticized as propofol was ti-
trated manually in our control group to achieve set
points that are commonly used during anesthesia, i.e.,
blood pressure, heart rate, and sympathetic tone while
using BIS in the closed-loop control group.22 There-
fore, in this study, we allowed the clinician to see and
use the BIS online and to use similar TCI algorithm
and titration limits as the closed-loop control system
in order to approach the closed-loop control group
methodology as close as possible. Although our
closed-loop control system would have been able to
compensate for interindividual variability, we aimed
at studying a very homogenous patient population. As
a result, the only real difference between the two
study populations was the automated or manual
control of the hypnotic component of anesthesia. As
stated in an editorial by Glass and Rampil,22 it is
important to underline the critical role of analgesia in
the performance of hypnotic control. High dosages of
opiates will dampen the arousal effects caused by a
noxious stimulus23 hereby requiring much smaller
adjustments in propofol concentration. As the ovum
retrieval procedure only requires a small dose of
opiates, the performance of control was not influenced
by high opiate concentrations. The noxious stimuli
during this procedure are very homogeneous in all
patients. Additionally, as all patients were aimed at
breathing spontaneously and could move during the
procedure, this introduced a lot or performance chal-
lenges for both human and automated control.
This closed-loop controller is able to manage
both induction of anesthesia and pharmacodynamic
changes during the case. This is due to the application
of the Bayesian optimization technology. For the in-
duction, we showed that our closed-loop control sys-
tem performed better compared with the manually
induced patients with similar times to reach the set
point but with less overshoot and faster return to the
set point after the initial overshoot, even though both
the closed-loop controller and the clinician in the
manual control group started with a same CePROP
target of 5 g/mL. The beneficial results for closed-
loop control are due to the fact that the closed-loop
controller will correct faster (even during the bolus)
when individual patient drug response (BIS change)
becomes available while a human operator will “wait
and see” before he or she corrects.
During maintenance, the clinical performance goal
of any control system, both human and automated, is
to provide tight control. For BIS, adequate levels of
control were defined as having a BIS value within 10
BIS units of the set point.3 Table 3 demonstrates that
closed-loop control offered accurate control during
significantly more percentages of case time. Hereby, it
is important to state that the analyzed time period
starts and stops at start and termination of propofol
administration, so includes the induction phase. In
this study, induction is an integral part of the control
period and included in the analysis. In the manual
control, it can be observed that a too deep level of
anesthesia caused worse control.
Additionally, robustness of the controller should be
proven. O’ Hara and colleagues24 proposed the goals
of control in anesthesia as (1) keeping the average
value of the controlled variable within defined limits;
(2) minimizing oscillations in the controlled variable
within these limits, and (3) guaranteeing stability so
that over time the size of the oscillations either be-
comes smaller or remains constant at an acceptable
level, rather than increasing. A mathematical interpre-
tation of these criteria can be found in Varvel and
co-workers20 for computer-controlled infusion pumps,
which can be applied on closed-loop controller perfor-
mance after minor modifications.3 As observed in
Table 4 and Figure 2, overall and time specific PE’s
were significantly better in the closed-loop than
manual control group. All derived performance pa-
rameters (MDPE, MDAPE, divergence, and wobble)
were significantly better in our closed-loop control
group compared with the manual control group.
Hereby, it is important to underline that the results
of the closed-loop controller are clinically acceptable
alone, even without comparing it with a manually
controlled group. The performance results from the
manual control group can be used to have an idea of
the performance of the trained clinician and as such, to
compare absolute performance values. MDPE indi-
cates the bias of the controller without revealing any
information neither on dynamic or higher-frequency
behavior nor on the amplitude of possible oscillations
in control. Note that MDPE is a signed value and thus
represents the direction (over- or underprediction) of
the performance errors rather than the size of the
errors, which is represented by MDAPE. Even though
MDAPE does not indicate the sign of a possible bias, it
describes both the amplitude of possible bias as well
as all other errors that prevent the controller from
approaching the control target. Note that in MDPE is
negative when applying our closed-loop control sys-
tem, which indicates that the system tend to overdose,
leading to BIS levels below target. This can be attrib-
uted to the fact that closed-loop control for drug
delivery performs, in essence, an asymmetric control
operation. They only govern the infusion, not the
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elimination of drug from the body, which is a slower
process. This phenomenon has been observed in our
earlier studies as well.10 Divergence and wobble indi-
cates to the oscillation of the controller behavior
(wobble) and the tendency of the controller to con-
verge on the target over a longer time (divergence). A
negative divergence number indicates convergence to
the target. The absolute value indicates the speed of
convergence or divergence. As shown in Table 4, the
divergence in the closed-loop control group shows an
average negative number in contrast to the manual
control group. A careful interpretation of Figure 2D
shows that, after initially reaching the target, the
manual control group drifts to significantly lower BIS
values needing more time to correct. This episode
might remain dominant in the divergence number,
falsely suggesting that control in the manual control
group will keep on diverging. This, obviously, does
not reduce the significance of the negative divergence
in the control group.
Whereas model based adaptive control is not new,
the integration of Bayesian methods for model estima-
tion is a new method. The Bayesian approach starts
out using population based parameter values and
individualizes them according to knowledge acquired
about the specific patient during treatment. As a clear
deviation is seen between the controller based on the
Bayesian-estimated curve and a hypothetical control-
ler using the unchanged typical values, the added
complexity is justified.
The net positive sum in Figure 4F demonstrates
that, on average, the Bayesian controller causes a
faster response for drug increase than the original
controller, except for one patient where the accumu-
lated difference remains close to zero.
The change in typical value is apparent for the ce50
and delay, which are estimated in the Bayesian ap-
proach. Despite of  being held constant, the slope of
the curve will still change during the case. This is
illustrated by plotting the concentration changes pro-
posed by the two controllers.
A significantly better recovery profile was observed
in the closed-loop control group than the manual
control group, both for time until opening of the eyes
and saying name and birth date. Because of the short
duration and homogenous characteristics of the pro-
cedure, the differences in recovery times are perhaps
clinically less important than found in previous work
with longer cases.10 As BIS nor CePROP were different
at the end of the propofol infusion although we found
a longer recovery times in the manual control group
and more propofol given, the dosing history and its
related context sensitive decrement times might be
responsible for the differences in recovery profiles.
Before being able to introduce automated control
into clinical practice, it has to be proven that it is as
clinically feasible as manual control.22 Therefore, the
presence of a control group where a human operator is
in charge of controlling a similar system under similar
circumstances is essential, as neither well-described
criteria nor guidelines are available in the literature.
We found that our closed-loop control system resulted
in similar hemodynamic and respiratory stability than
manual control. Even though some lower MAP was
found just after induction, no episodes of severe
hypotension nor hypertension were found. Heart rate
and saturation remained as stable as in the manual
control group. It is important to state that patients
remained breathing spontaneously which is challeng-
ing for whatever control system. During these proce-
dures, patients were allowed to move their feet,
hands, or head. However, the upper legs and pelvis
should remain steady as this might result in a short
lasting interruption of the retrieval and will upset the
gynecologist. Similar results for movement and
overall score were found. These results indicate the
stability of control under difficult conditions for the
operator. It has to be noted that movement response
was not and cannot be controlled with a our closed-
loop control system, as it depends on the given dose of
antinociceptive drugs. At its best, control of the hyp-
notic component of anesthesia can manage possible
arousal reflexes caused by nociceptive stimuli.
It has to be stressed that one should be careful not
to extrapolate these results for other patient groups.
This was a first feasibility study and as such, we
cannot claim full clinical safety, accuracy nor utility.
To reach this goal, a large multicenter study is re-
quired to investigate the behavior of the system in
various populations and specific surgical situations.
Additionally, the design and implementation of intel-
ligent alarm systems have to be considered. Although
the anesthesiologist in charge of the manual control
group has been never involved in the development of
this closed-loop system, we accept the possible limi-
tations and bias.
In conclusion, our closed-loop control system ti-
trated propofol administration accurate resulting in
BIS values close to the set point and was able to induce
the patients within clinical accepted time limits and
with less overshoot than the manual control group.
Additionally, the overall control system revealed an
acceptable robustness. Patients in the closed-loop con-
trol group woke up faster. Our closed-loop control
group showed to be clinically feasible compared to a
manual control group specified by similar hemody-
namic, respiratory stability, comparable movement
and quality scores.
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